Realbotix Reports Financial Results for Q2-2026
Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF), a developer of humanoid robots and AI systems for enterprise and consumer use, reported interim results for the three and six months ended March 31, 2026 (Q2-2026). All figures are in USD unless otherwise noted. Revenue declined year over year as the Company exited crypto-related activities and reallocated capital to its AI-integrated humanoid robotics division, while a one-time gain lifted quarterly comprehensive income.
Key Financials (Q2-2026 and H1-2026)
- Revenue: $225,000 (Q2) and $578,000 (H1), versus $727,000 and $1,543,000 in the prior-year periods. Management attributes the decline to the wind-down of crypto-staking and ancillary crypto operations, a shift of resources to humanoid robotics, and streamlining of legacy products.
- Gross margin: -1.7% (Q2) and 19.0% (H1), compared to 48.6% and 45.9% a year ago. The negative quarterly margin reflects a one-time accounting adjustment moving certain overhead into cost of sales, which was not present last year.
- Operating expenses: $1,746,000 (Q2) and $3,423,000 (H1), up from $1,318,000 and $3,267,000, driven by hiring and scaling in humanoid robotics and AI.
- Total comprehensive income (loss): $442,375 (Q2) and $(849,000) (H1), versus $(4,858,000) and $(3,940,000) in the prior-year periods. The improvement reflects a one-time gain on debt repayment, the sale of the Tokens.com domain, and no further crypto asset revaluation impacts, partially offset by softer gross margin and higher OpEx.
Strategic Shift to Humanoid Robotics and AI
Realbotix is concentrating on the human interface layer of robotics—where lifelike expression, natural motion, conversational ability, and emotional intelligence are key to user acceptance. The Company highlights its portfolio of proprietary technologies and patents as competitive moats in environments where trust, communication, and empathy matter, including healthcare and assistive care.
While the humanoid category remains early—an estimated 13,000 robots sold worldwide in 2025, with one vendor holding roughly 40% in lower-cost novelty models—Realbotix is targeting socially intelligent, human-like interaction for workforce and visitor engagement. To meet emerging demand, the robotics AI and engineering team expanded from 8 employees a year ago to 20 full-time equivalents.
Deliveries, Pipeline, and Revenue Recognition
Following an April 1 update, Realbotix confirmed it has begun product deliveries, including a completed deployment to a large telecommunications client in April. Consistent with its policy of recognizing revenue upon delivery, these amounts were not reflected in the March 31 quarter. Management expects additional deliveries in the coming months.
“We’re seeing rising interest from healthcare and education, and are now receiving orders for real-world deployments,” said CEO Andrew Kiguel, who added that reported revenue lags execution due to the timing of delivery and recognition. The Company remains focused on scaling production capacity to meet anticipated demand.
Nasdaq Listing Plan via ONCO Transaction
Realbotix has entered a previously announced transaction to list its wholly owned subsidiary, Realbotix LLC, on the Nasdaq Capital Market through a reverse takeover of Onconetix, Inc. (NASDAQ: ONCO). The Company expects the transaction to close before October 31, 2026. Management believes a Nasdaq listing would broaden access to institutional investors, improve liquidity and visibility, and better align Realbotix with global AI and robotics peers as it moves from demonstrations to wider commercial rollouts.
Investor Webinar
- Date: May 29, 2026
- Time: 3:00 pm ET
- Zoom Registration: Register here
After registering, attendees will receive a link via email. The webinar can be accessed on computer, tablet, or smartphone. A dial-in option will be provided for listen-only access; dial-in participants will not be able to join the Q&A.
Regulatory Filings
A complete financial package, including Interim Financial Statements and MD&A, is available on SEDAR+: www.sedarplus.ca.
About Realbotix
Realbotix develops humanoid robots and AI systems designed for human interaction across enterprise and consumer settings. Manufactured in the United States, its patented AI and robotics stack powers lifelike expressions, motion, agentic vision, and social engagement.
Product site: Realbotix.com | Corporate/Investor site: Realbotix.AI
Follow the Company on Twitter, LinkedIn, and YouTube. Follow Aria, the humanoid robot, on X, Instagram, and TikTok.
Contacts
- Andrew Kiguel, CEO — Contact@realbotix.com
- Jennifer Karkula, Head of Communications — Contact@realbotix.com
- Media — media@realbotix.com
- Sales — sales@realbotix.com
- Telephone: 647-578-7490
Source: Business Wire
Forward-Looking Statements
This article contains forward-looking information based on current expectations and assumptions and is subject to risks and uncertainties that may cause actual results to differ materially. Readers should not place undue reliance on forward-looking statements. See the Company’s filings at sedarplus.ca for further risk disclosures. Realbotix undertakes no obligation to update forward-looking statements except as required by law. The TSX Venture Exchange and its Regulation Services Provider accept no responsibility for the adequacy or accuracy of this release.
